Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
about
Bone cancer pain: from mechanism to therapyPathogenesis and clinical aspects of pain in patients with osteoporosisNociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation.Balloon kyphoplasty in malignant spinal fractures: a systematic review and meta-analysis.Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3Bone cancer pain.Pharmacodynamics of bisphosphonates in arthritis.Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain.Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid.Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid.Mice with cancer-induced bone pain show a marked decline in day/night activity.Monitoring changes in quality of life in patients with lung cancer under treatment with chemotherapy and co administration of zoledronic acid by using specialized questionnaires.Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.Pain outcomes in patients with advanced breast cancer and bone metastases
P2860
Q27025262-2B235B07-E2E6-4A10-B4E7-E2C5839DD83AQ28082567-5AB17E86-21A0-4EED-B712-B4C85473C721Q30453959-F586AE56-B8FC-4085-B76B-71D03EA128DAQ33501367-39877ED7-8CE9-4379-B128-8FBFCE4AE280Q33911367-0AC2AF2D-5CDB-4850-B773-6FDA5C7D8939Q34120101-82193485-85DE-464D-9F39-D1EFDA736BBDQ37973356-E1412EBE-FC3F-4558-B939-3855059AE0A9Q38297692-04FEF3E3-BD8E-4BB6-ABA8-7E2FAAA82935Q39033886-E686A999-6DE2-442D-BEE6-9E17CBA1AB23Q47705480-34DB5919-DC33-4397-B40C-BC0DE7752054Q48408434-94E1462A-A13F-4D4E-BA60-35619F9F10E9Q49384627-23238B7F-7E64-4110-8D24-BB3254EB7758Q55023616-7F739471-7A66-47F3-861B-E9DF8A7FFB8DQ55117611-90861F92-3DF0-4C7B-AFA3-079E9CEFF6ECQ56550928-86B805B5-6342-4CB2-A211-86B07F78C88A
P2860
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@en
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@nl
type
label
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@en
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@nl
prefLabel
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@en
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@nl
P2093
P2860
P1476
Metastatic bone pain: treatment options with an emphasis on bisphosphonates.
@en
P2093
Florian Strasser
Kathrin Zaugg
Roger von Moos
Silke Gillessen
P2860
P2888
P304
P356
10.1007/S00520-008-0487-0
P577
2008-08-06T00:00:00Z